Early investigational TNF receptor antagonists for the treatment of ulcerative colitis.
about
Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published EvidenceSuccessful sofosbuvir treatment with ribavirin dose reduction for chronic hepatitis C virus genotype 2 infection in a patient with ulcerative colitis: a case report.Molecular topology: a strategy to identify novel compounds against ulcerative colitis.
P2860
Early investigational TNF receptor antagonists for the treatment of ulcerative colitis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Early investigational TNF receptor antagonists for the treatment of ulcerative colitis.
@en
type
label
Early investigational TNF receptor antagonists for the treatment of ulcerative colitis.
@en
prefLabel
Early investigational TNF receptor antagonists for the treatment of ulcerative colitis.
@en
P2860
P1476
Early investigational TNF receptor antagonists for the treatment of ulcerative colitis.
@en
P2093
Ian C Lawrance
P2860
P304
P356
10.1517/13543784.2015.1020371
P407
P577
2015-02-26T00:00:00Z